RBS-2418

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameRBS-2418
Drug Alias NameRBS-2418
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionImmunomodulatorsStimulator of interferon genes stimulantsEctonucleotide Pyrophosphatase/Phosphodiesterase 1 inhibitors
TargetsStimulator of interferon genesEctonucleotide Pyrophosphatase/Phosphodiesterase 1
Therapy Area/IndicationsNeoplasm MetastasisColorectal NeoplasmsCarcinoma, Hepatocellular +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesVietnamPuerto Rico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesRiboscience LLC
China Registration ClassN/A

Develop Information

Active CompaniesRiboscience LLC
Inactive CompaniesN/A
Active IndicationsNeoplasm MetastasisColorectal NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A